Pituitary-adrenocortical effect of short- and long-term progestational therapy.
D015068:17-Ketosteroids / Q000652:urine; D000305:Adrenal Cortex Hormones / Q000097:blood; D000328:Adult; D002715:Chlormadinone Acetate / Q000008:administration & dosage / Q000494:pharmacology; D005040:Ethynodiol Diacetate / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D006801:Humans; D008797:Metyrapone; D009640:Norethindrone / Q000008:administration & dosage / Q000494:pharmacology; D009641:Norethynodrel / Q000008:administration & dosage / Q000494:pharmacology; D010912:Pituitary-Adrenal Function Tests; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011372:Progestins / Q000008:administration & dosage* / Q000494:pharmacology
D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D011372:Progestins; D002715:Chlormadinone Acetate; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D009640:Norethindrone; D008797:Metyrapone